Concinnity Genetics Secures £3M Seed Funding for Gene Therapy Innovations

Deal News | Jan 21, 2025 | Maven Capital Partners

Concinnity Genetics Secures £3M Seed Funding for Gene Therapy Innovations

Concinnity Genetics, an Edinburgh University spinout, has raised £3 million in a seed funding round led by Eos Advisory, with participation from Scottish Enterprise, Old College Capital, and IFS Maven Equity Finance. With this funding, Concinnity aims to advance its AI-driven RNA platform for gene control systems, pivotal for gene and cell therapies. The company employs synthetic biology to create precise RNA-based control systems, important for post-dosing gene therapy safety and efficacy. The investment will fuel the development of three new programs targeting gene therapies and support the growth of its existing technology. Founded by bioengineers Jessica Birt and Dr. Matthew Dale, Concinnity reflects Scotland's leading role in synthetic biology and global healthcare innovation.

Sectors

  • Biotechnology
  • Investment & Venture Capital

Geography

  • Scotland – Concinnity Genetics and IFS Maven Equity Finance are both based in Scotland, where the investment is focused.

Industry

  • Biotechnology – The article focuses on Concinnity Genetics, a biotechnology company specializing in AI-driven RNA design platforms for gene therapies.
  • Investment & Venture Capital – The article involves IFS Maven Equity Finance, a venture capital firm investing in high-potential businesses in Scotland.

Financials

  • £3 million – The total seed funding raised by Concinnity Genetics.

Participants

NameRoleTypeDescription
Concinnity GeneticsTarget CompanyCompanyAn Edinburgh University spinout developing AI-driven RNA design platforms for gene control.
IFS Maven Equity FinanceInvestorCompanyA financial investment firm supporting early-stage and growth businesses in Scotland.
Eos AdvisoryInvestorCompanyLed the seed funding round for Concinnity Genetics.
Scottish EnterpriseInvestorGovernmentSupported the funding round for Concinnity Genetics.
Old College CapitalInvestorCompanyThe University of Edinburgh's venture investment fund.
University of EdinburghSupportCompanyThe academic institution from which Concinnity Genetics was spun out.